PLUS THERAPEUTICS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Plus Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $925K, a 2791% increase year-over-year.
  • Plus Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.77M.
  • Plus Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $5K.
  • Plus Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$563K, a 37.9% increase from 2021.
  • Plus Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$907K, a 168% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.77M $925K +$893K +2791% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $875K $757K +$749K +9363% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $126K $38K +$121K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5K $48K +$134K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$129K $32K +$157K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$286K $8K +$170K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$456K -$83K +$107K +56.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$563K -$86K +$130K +60.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$693K -$125K +$100K +44.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$793K -$162K +$63K +28% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$856K -$190K +$51K +21.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-20
Q4 2021 -$907K -$216K -$24K -12.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$883K -$225K +$107K +32.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-20
Q2 2021 -$990K -$225K -$738K -144% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-21
Q1 2021 -$252K -$241K -$1.6M -118% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-21
Q4 2020 $1.34M -$192K -$3.33M -106% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $4.67M -$332K +$1.82M +84.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-21
Q2 2020 $2.85M $513K +$821K Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $2.03M $1.35M +$1.65M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $374K $3.13M +$3.23M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-22
Q3 2019 -$2.86M -$2.15M -$2.99M -359% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-22
Q2 2019 $126K -$308K +$131K +29.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$5K -$298K +$111K +27.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$116K -$99K +$557K +84.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$673K $831K +$1.3M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.97M -$439K +$29K +6.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 -$2M -$409K +$6K +1.45% Jan 1, 2018 Mar 31, 2018 8-K 2019-09-10
Q4 2017 -$2M -$656K +$674K +50.7% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-09
Q3 2017 -$2.68M -$464K +$123K +21% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.8M -$468K -$287K -159% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.51M -$415K -$173K -71.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$2.34M -$1.33M -$645K -94.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$1.7M -$587K -$117K -24.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-09
Q2 2016 -$1.58M -$181K +$1.16M +86.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-09
Q1 2016 -$2.74M -$242K +$719K +74.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-09
Q4 2015 -$3.46M -$685K +$755K +52.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$4.21M -$470K +$1.03M +68.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-24
Q2 2015 -$5.24M -$1.34M -$199K -17.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-24
Q1 2015 -$5.04M -$961K -$108K -12.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-24
Q4 2014 -$4.93M -$1.44M -$517K -56% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$4.41M -$1.5M -$4.7M -147% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 $284K -$1.14M -$4.3M -136% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 $4.58M -$853K +$77K +8.28% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 $4.5M -$923K +$139K +13.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 $4.36M $3.2M +$4.12M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 $244K $3.15M +$4.08M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$3.83M -$930K +$30K +3.13% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$3.86M -$1.06M -$130K -13.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$3.73M -$916K -$404K -78.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$3.33M -$923K -$157K -20.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$3.17M -$960K -$131K -15.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$3.04M -$932K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$512K +$314K +38% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$766K -$431K -129% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$829K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$826K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$335K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.